Bradford J. Pinkos, Dmd, Llc in Bridgewater, CT - Dentist

Bradford J. Pinkos, Dmd, Llc is a dental clinic (Dentist - General Practice) in Bridgewater, Connecticut. The current practice location for Bradford J. Pinkos, Dmd, Llc is 29 Planz Ln, Bridgewater, Connecticut. For appointments, you can reach them via phone at (860) 799-6996. The mailing address for Bradford J. Pinkos, Dmd, Llc is 29 Planz Ln, Bridgewater, Connecticut and phone number is (860) 799-6996.

Bradford J. Pinkos, Dmd, Llc is licensed to practice in Connecticut (license number 011546) and its NPI number is 1063869162. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (860) 799-6996.

Contact Information

	Bradford J. Pinkos, Dmd, Llc
	29 Planz Ln Bridgewater CT 06752-1235
	(860) 799-6996
	Not Available

Dental Care Clinic Profile

Full Name	Bradford J. Pinkos, Dmd, Llc
Speciality	Dentist - General Practice
Location	29 Planz Ln, Bridgewater, Connecticut
Authorized Official Name and Position	Bradford Joseph Pinkos (OWNER)
Authorized Official Contact	2037335258
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bradford J. Pinkos, Dmd, Llc 29 Planz Ln Bridgewater CT 06752-1235 Ph: (860) 799-6996	Bradford J. Pinkos, Dmd, Llc 29 Planz Ln Bridgewater CT 06752-1235 Ph: (860) 799-6996

NPI Details:

NPI Number	1063869162
Provider Enumeration Date	05/18/2016
Last Update Date	05/18/2016

Medical Identifiers

Medical identifiers for Bradford J. Pinkos, Dmd, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063869162	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	011546 (Connecticut)	Primary

News Archive

Study confirms Stretta therapy as safe, effective treatment for GERD

A newly published peer-reviewed paper concludes that Stretta therapy is a safe, effective and durable treatment for gastro esophageal reflux disease (GERD). The paper states that Stretta addresses a significant unmet need where patients receive inadequate control from PPI therapy and find surgery an undesirable option.

AHCA intents to award contract for MMA program to Centene's Florida subsidiary

Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.

Elorac acquires world-wide rights to Cidoxepin

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, is pleased to announce that it has acquired world-wide rights to the active agent Cidoxepin from Gideon Pharmaceuticals. Cidoxepin is the cis-isomer of the widely prescribed tricyclic compound doxepin.

Splicing findings offer lung cancer clues

Researchers from Spain have identified several new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer, suggesting that their dysregulation is involved in the pathogenesis of the disease.

Bradford J. Pinkos, Dmd, Llc - Dental Clinic in Bridgewater, CT